Complete remission of gallbladder neuroendocrine carcinoma with liver metastasis by tislelizumab plus chemotherapy: a case report

Overview of attention for article published in Frontiers in oncology, January 2024

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (51st percentile)

Mentioned by

twitter: 3 X users

Readers on

mendeley: 2 Mendeley

Summary X

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 38,105 followers.

Complete remission of gallbladder neuroendocrine carcinoma with liver metastasis by tislelizumab plus chemotherapy: a case report: Background Gallbladder neuroendocrine carcinoma (GB-NEC) is an extremely rare cancer with a poor…… #oncology https://t.co/n

04 Feb 2024

Reply Repost Favourite

RT @FrontOncology: New research: Complete remission of gallbladder neuroendocrine carcinoma with liver metastasis by tislelizumab plus chem…

01 Feb 2024

Reply Repost Favourite

New research: Complete remission of gallbladder neuroendocrine carcinoma with liver metastasis by tislelizumab plus chemotherapy: a case report: Background Gallbladder neuroendocrine carcinoma (GB-NEC) is an extremely rare cancer with a poor… https://t.co

01 Feb 2024

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.